[1]
Solecka, K. et al. 2026. Gepants in Migraine Treatment: Cardiovascular Safety and Clinical Implications. Quality in Sport. 74, (Sep. 2026), 74997. DOI:https://doi.org/10.12775/QS.2026.74.74997.